Mestanolone

Mestanolone 

Basic Information:

Product name	Mestanolone (Steroids)
Other name	Methyldihydrotestosterone; Mestaline; Methylandrostanolone; 3-Keto-17b-Hydroxy-17a-Methyl-5a-Androstane; 17alpha-Methyldihydrotestosterone 5alpha-Androstane-17alpha-Methyl-17beta-Ol-3-One; 5-Alpha-Androstan-17-Alpha-Methyl-17-Beta-Ol-3-One;
CAS register number	521-11-9
EINECS	208-302-6
Molecular formula	C20H32O2
Molecular weight	304.47
Molecular structure
Appearance	White or Similar crystalline powder
Solubility	Soluble in acetone, ethanol, ethyl ether, ethyl acetate, insoluble in water
Melting point	224-226°C
Assay	99%
Packing	1kg/tin/foil bag

Description:

Ermalone, a.k.a. methyldihydrotestosterone, mestanolone, and methyl-DHT is a modified version of dihydrotestosterone (DHT), an anabolic steroid that was designed to treat testosterone deficiency in males. Its c-17alpha alkylated modification allows it safe passage through the liver - the body's primary filter for everything that's orally ingested.

Since no further structural modification was added to protect the 3-ketone group, Ermalone is rapidly broken down within skeletal muscle tissue by the 3-alpha hydroxysteroid dehydrogenase enzyme. As a consequence, this oral androgen has an activity profile very similar to other non-aromatizing DHT-derived steroids like Winstrol and Oral Turinabol.

The recommended dosage for Ermalone users is 10-20 mg/day for 6-8 weeks, which is often enough to keep blood serum levels well above baseline with this particular drug. More specifically, Ermalones strength and muscle gains are largely on par with those of the DHT-derived anabolic steroid Winstrol (Stanozolol). Its anabolic and androgenic effects are typically dose dependent and extremely supportive of testosterone-based cycles. Experienced steroid users have been known to run more aggressive dosages of 30 mg/day of methyldihydrotestosterone.

Applications:

used in the treatment of penile erectile dysfunction (ED).

The primary indication of sildenafil is treatment of erectile dysfunction (inability to sustain a satisfactory erection to complete intercourse). Its use is now standard treatment for erectile dysfunction in all settings, including diabetes.

People on antidepressants may experience sexual dysfunction, either as a result of their illness or as a result of their treatment. A 2003 study showed that sildenafil improved sexual function in men in this situation. Following up reports from 1999, the same researchers found that sildenafil improved sexual function in female patients on antidepressants as well.